Acute Ischaemic Stroke |
- Sudden onset of focal neurological deficits, such as unilateral weakness, speech disturbances (aphasia), visual disturbances, or loss of coordination.
- Symptoms may be accompanied by headache, dizziness, or altered consciousness.
- Risk factors include hypertension, atrial fibrillation, diabetes, and previous stroke.
|
- Non-contrast CT scan of the head to exclude haemorrhage and confirm ischaemic stroke.
- MRI of the brain for more detailed imaging in ischaemic stroke.
- ECG to detect atrial fibrillation, echocardiography to assess for cardiac emboli.
- Blood tests including glucose, electrolytes, coagulation profile, and cardiac enzymes.
|
- Thrombolytic therapy (e.g., IV alteplase) within 3-4.5 hours of symptom onset for eligible patients.
- Aspirin for patients not eligible for thrombolysis or as secondary prevention.
- Endovascular thrombectomy for large vessel occlusions if within 24 hours of onset.
- Management of blood pressure, blood glucose, and other risk factors.
- Rehabilitation and secondary prevention strategies, including antiplatelet therapy and statins.
|
Intracerebral Haemorrhage |
- Sudden onset of severe headache, vomiting, altered mental status, and focal neurological deficits.
- May present with rapidly increasing symptoms of raised intracranial pressure (e.g., decreased level of consciousness, pupil abnormalities).
- Commonly associated with hypertension, anticoagulation, or vascular abnormalities (e.g., aneurysms, AV malformations).
|
- Non-contrast CT scan of the head to identify the location and extent of bleeding.
- Blood tests including complete blood count (CBC), coagulation profile, renal and liver function tests.
- Consider MRI or CT angiography if vascular malformation is suspected.
|
- Immediate blood pressure control, often with IV antihypertensives (e.g., labetalol, nicardipine).
- Reversal of anticoagulation if applicable (e.g., vitamin K, prothrombin complex concentrate for warfarin).
- Surgical intervention (e.g., decompressive craniectomy, evacuation of haematoma) in selected cases.
- Monitoring in an ICU setting for signs of increased intracranial pressure or herniation.
|
Subarachnoid Haemorrhage |
- Sudden onset of "thunderclap" headache, often described as the worst headache of the patient’s life.
- May be associated with neck stiffness, photophobia, nausea, vomiting, and loss of consciousness.
- Commonly caused by rupture of a cerebral aneurysm or arteriovenous malformation (AVM).
|
- Non-contrast CT scan of the head to identify subarachnoid blood.
- Lumbar puncture if CT is negative but suspicion remains high; looking for xanthochromia and RBCs in the CSF.
- CT or MR angiography to identify the source of bleeding (e.g., aneurysm, AVM).
|
- Early neurosurgical or endovascular intervention (e.g., aneurysm clipping or coiling).
- Control of blood pressure to prevent rebleeding (e.g., with IV labetalol, nimodipine to prevent vasospasm).
- Supportive care including pain management, anticonvulsants if seizures occur, and monitoring in an ICU setting.
|
Status Epilepticus |
- Continuous or recurrent seizures lasting more than 5 minutes without regaining consciousness between episodes.
- May present with tonic-clonic movements, altered consciousness, and possible respiratory compromise.
- Common causes include epilepsy, head trauma, CNS infections, and withdrawal from antiepileptic drugs.
|
- Clinical diagnosis based on seizure activity.
- Blood tests including glucose, electrolytes, and toxicology screen to identify precipitating factors.
- Consider CT or MRI brain to rule out structural abnormalities if the cause is unclear.
- EEG monitoring in refractory cases to assess seizure activity and response to treatment.
|
- Immediate administration of IV benzodiazepines (e.g., lorazepam, diazepam) to terminate seizures.
- Follow with IV antiepileptics (e.g., phenytoin, valproate) if seizures persist.
- ICU admission for continuous EEG monitoring and management if seizures are refractory.
- Identify and treat underlying causes (e.g., infection, electrolyte imbalance).
|
Guillain-Barré Syndrome |
- Progressive symmetrical weakness starting in the legs and ascending to involve the arms and respiratory muscles.
- May be associated with paresthesia, areflexia, and autonomic dysfunction (e.g., tachycardia, blood pressure instability).
- Often follows a recent infection, such as Campylobacter jejuni, influenza, or CMV.
|
- Clinical diagnosis supported by nerve conduction studies showing demyelination.
- CSF analysis may show elevated protein with normal cell count (albuminocytologic dissociation).
- Pulmonary function tests (e.g., vital capacity) to assess respiratory muscle involvement.
- Consider MRI spine if diagnosis is unclear or to rule out other causes of weakness.
|
- Plasmapheresis or intravenous immunoglobulin (IVIG) to reduce immune-mediated nerve damage.
- Supportive care, including monitoring of respiratory function and ICU admission if respiratory failure is imminent.
- Physical therapy to maintain muscle strength and prevent complications from immobility.
- Monitor for complications such as autonomic dysfunction and deep vein thrombosis (DVT).
|
Meningitis |
- Fever, headache, neck stiffness, photophobia, and altered mental status.
- May present with a rash, particularly in meningococcal meningitis.
- Can be caused by bacterial, viral, or fungal infections, with bacterial meningitis being the most severe.
|
- Blood cultures and lumbar puncture to obtain CSF for analysis (e.g., cell count, glucose, protein, Gram stain, culture).
- CT scan of the head may be done prior to lumbar puncture if there are signs of raised intracranial pressure.
- CSF analysis showing elevated white cells, low glucose, and high protein in bacterial meningitis.
- Consider PCR or serology for specific pathogens, especially in viral meningitis.
|
- Empirical IV antibiotics (e.g., ceftriaxone, vancomycin) started immediately after blood cultures are taken.
- IV corticosteroids (e.g., dexamethasone) may be used to reduce inflammation in bacterial meningitis.
- Supportive care including IV fluids, antipyretics, and monitoring for complications such as seizures or septic shock.
- Isolation and public health notification if meningococcal meningitis is suspected.
|
Acute Myasthenic Crisis |
- Severe muscle weakness leading to respiratory failure, difficulty swallowing, and bulbar symptoms.
- May be triggered by infection, surgery, medication changes, or stress.
- Often occurs in patients with underlying myasthenia gravis, particularly those with thymoma.
|
- Clinical diagnosis based on history of myasthenia gravis and presentation of symptoms.
- Electromyography (EMG) showing decremental response to repetitive nerve stimulation.
- Serum antibodies against acetylcholine receptor (AChR) or muscle-specific kinase (MuSK) may be positive.
- Pulmonary function tests (e.g., forced vital capacity) to assess respiratory function.
|
- IVIG or plasmapheresis to rapidly reduce antibody levels and improve symptoms.
- High-dose corticosteroids or other immunosuppressive therapy to control the underlying disease.
- Monitoring and management of respiratory function in an ICU setting if necessary.
- Adjustment of medications that may worsen myasthenia (e.g., aminoglycosides, beta-blockers).
|
Acute Encephalitis |
- Fever, headache, altered mental status, seizures, and focal neurological deficits.
- May also present with behavioural changes, confusion, and coma in severe cases.
- Commonly caused by viral infections, such as herpes simplex virus (HSV), or autoimmune encephalitis.
|
- CSF analysis showing lymphocytic pleocytosis, normal or elevated protein, and normal glucose.
- MRI brain may show changes consistent with encephalitis, especially in the temporal lobes with HSV.
- EEG may show diffuse slowing or focal abnormalities.
- CSF PCR for HSV or other viral pathogens; autoimmune antibodies if autoimmune encephalitis is suspected.
|
- Empirical IV acyclovir should be started immediately if HSV encephalitis is suspected.
- Supportive care including IV fluids, seizure management, and monitoring of intracranial pressure.
- Immunotherapy (e.g., steroids, IVIG, plasmapheresis) for autoimmune encephalitis.
- Consider transfer to an ICU for severe cases with altered mental status or respiratory compromise.
|
Acute Subdural Haematoma |
- Headache, confusion, drowsiness, and focal neurological deficits, often following head trauma.
- May present with loss of consciousness followed by a lucid interval, then deterioration.
- More common in elderly patients or those on anticoagulants.
|
- Non-contrast CT scan of the head showing crescent-shaped hyperdense area.
- MRI may be used in subacute or chronic cases to assess the extent of the haematoma.
- Coagulation profile and blood tests to assess for anticoagulation status and overall health.
|
- Surgical intervention (e.g., craniotomy, burr hole evacuation) for large or symptomatic haematomas.
- Reversal of anticoagulation if the patient is on anticoagulants (e.g., vitamin K, FFP).
- Monitoring for signs of increased intracranial pressure and neurological deterioration.
- Rehabilitation and monitoring for potential long-term neurological deficits.
|